Trials / Completed
CompletedNCT01026584
Efficacy and Safety of Aripiprazole in First Episode Psychosis
Efficacy and Safety of Aripiprazole in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate the efficacy and safety of aripiprazole in patients with first episode psychosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole | 6 week prospective study |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2009-12-04
- Last updated
- 2012-02-13
Locations
13 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01026584. Inclusion in this directory is not an endorsement.